Hepatitis B Surface Antibody | Back to Test Directory | ||||
Test Description |
|
||||
Qualitative and quantitative determination of antibody to hepatitis B surface antigen. | |||||
Performed | Avg. Turnaround Time | Method | |||
Coralville, 8 a.m. - 5 p.m., M-F |
5 - 7 business days | Chemiluminescent Immunoassay (CLIA) - DiaSorin | |||
Fee | CPT Code(s) | ||||
$20.40 | 86706 | ||||
Specimen Requirements | |||||
Specimen Type: | Minimum 1 mL Serum | ||||
Collection Instructions: |
Red Top Tube: centrifuge and transfer serum to a secondary tube. |
||||
Temperature and Stability: | Refrigerated (2-8°C); stable for 2 weeks. | ||||
Unacceptable Conditions: | Plasma, CSF. Contaminated, heat-inactivated, hemolyzed, or severely lipemic specimens. | ||||
Expected Results: | Negative or Positive and value in mIU/mL | ||||
Shipping Instructions | |||||
Wrap specimen container in absorbent material and place inside a biohazard bag. Transport specimen with cold pack. Ship to the Coralville location. | |||||
Comments | |||||
For a positive result: CDC guidelines currently state that a value of >=10 mIU/mL indicates recovery from acute or chronic hepatitis B virus infection or acquired immunity from HBV vaccination. This assay does not differentiate between a vaccine-induced immune response and an immune response induced by infection with HBV. For a negative result: CDC guidelines currently state that a value of <10.00 mIU/mL indicates a lack of recovery from acute or chronic hepatitis B or inadequate immune response to HBV vaccination. | |||||
Alternate Names | |||||
HBV surface antibody, HBsAb, Hepatitis B Immunity |